{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:31:51Z","timestamp":1791952311174,"version":"4.3.4"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/AuthorWarrantyLicense.v1"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"HHS | Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["N\/A Congressional funding"],"award-info":[{"award-number":["N\/A Congressional funding"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2021,10,19]]},"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19) pandemic reduced the sexually transmitted infection (STI) testing volume due to social-distancing and stay-at-home orders, among other reasons. These events highlighted previously known benefits of at-home STI self-testing or specimen self-collection and accelerated testing demand via telemedicine.<\/jats:p>","DOI":"10.1128\/jcm.02646-20","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T02:06:07Z","timestamp":1623377167000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":59,"title":["At-Home Specimen Self-Collection and Self-Testing for Sexually Transmitted Infection Screening Demand Accelerated by the COVID-19 Pandemic: a Review of Laboratory Implementation Issues"],"prefix":"10.1128","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-0324","authenticated-orcid":true,"given":"Ellen N.","family":"Kersh","sequence":"first","affiliation":[{"name":"Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Shukla","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Raphael","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Habel","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Park","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Issue brief. STI express services: increasing access and testing while maximizing resources.","author":"National Association of County and City Health Officials","year":"2019","unstructured":"National Association of County and City Health Officials. 2019. Issue brief. STI express services: increasing access and testing while maximizing resources. National Association of County and City Health Officials, Washington, DC. https:\/\/www.naccho.org\/uploads\/downloadable-resources\/issue-brief_STI-Express-Services.pdf."},{"key":"e_1_3_2_3_2","volume-title":"2018 STD surveillance report.","author":"Centers for Disease Control and Prevention","year":"2019","unstructured":"Centers for Disease Control and Prevention. 2019. 2018 STD surveillance report. Centers for Disease Control and Prevention, Atlanta, GA. https:\/\/www.cdc.gov\/nchhstp\/newsroom\/2019\/2018-STD-surveillance-report.html#:\u223c:text=According%20to%20the%20annual%20Sexually%20Transmitted%20Disease%20Surveillance,baby%20during%20pregnancy%E2%80%93%20increased%2040%20percent%20from%202017-2018. Accessed 7 September 2021."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ771"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1981"},{"key":"e_1_3_2_6_2","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","unstructured":"Centers for Disease Control and Prevention. 2014. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014. MMWR Recommend Rep 63:1\u201319.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001101"},{"key":"e_1_3_2_8_2","volume-title":"COVID-19 & the state of the STD field.","author":"National Coalition of STD Directors","year":"2020","unstructured":"National Coalition of STD Directors. 2020. COVID-19 & the state of the STD field. National Coalition of STD Directors, Washington, DC. https:\/\/www.ncsddc.org\/wp-content\/uploads\/2020\/05\/STD-Field.Survey-Report.Final_.5.13.20.pdf."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001313"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001309"},{"key":"e_1_3_2_11_2","volume-title":"WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights.","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019. WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001349"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000785"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00726-19"},{"key":"e_1_3_2_15_2","unstructured":"US Code. 1988. Title 42. The public health and welfare. Chapter 6A. Subchapter II. Part F. Subpart 2. Clinical laboratories. \u00a7 263a. Certification of laboratories. https:\/\/www.govinfo.gov\/content\/pkg\/USCODE-2011-title42\/pdf\/USCODE-2011-title42-chap6A-subchapII-partF-subpart2-sec263a.pdf."},{"key":"e_1_3_2_16_2","volume-title":"General checklist for establishment of performance specifications for tests not FDA-cleared or approved.","author":"APHL\/CDC STD Steering Committee","year":"2009","unstructured":"APHL\/CDC STD Steering Committee. 2009. General checklist for establishment of performance specifications for tests not FDA-cleared or approved. Association of Public Health Laboratories, Silver Spring, MD. https:\/\/www.aphl.org\/programs\/infectious_disease\/std\/Documents\/ID_2009Oct15_Checklist-STD-Performance-Specs.pdf."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001299"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1105"},{"key":"e_1_3_2_19_2","volume-title":"Aptima Combo 2 assay (Panther system).","author":"Hologic, Inc","year":"2019","unstructured":"Hologic, Inc. 2019. Aptima Combo 2 assay (Panther system). Hologic, Inc, San Diego, CA. https:\/\/www.hologic.com\/sites\/default\/files\/2019-12\/502446-IFU-PI_009_01.pdf."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa306"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104775"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-102"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajhb.22463"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.114913"},{"key":"e_1_3_2_25_2","volume-title":"FDA allows for first point-of-care chlamydia and gonorrhea test to be used in more near-patient care settings.","author":"US Food and Drug Administration","year":"2021","unstructured":"US Food and Drug Administration. 2021. FDA allows for first point-of-care chlamydia and gonorrhea test to be used in more near-patient care settings. US Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-allows-first-point-care-chlamydia-and-gonorrhea-test-be-used-more-near-patient-care-settings."},{"key":"e_1_3_2_26_2","volume-title":"How to obtain a CLIA certificate of waiver.","author":"Centers for Medicare and Medicaid Services","year":"2019","unstructured":"Centers for Medicare and Medicaid Services. 2019. How to obtain a CLIA certificate of waiver. Centers for Medicare and Medicaid Services, Baltimore, MD."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30734-9"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000974"},{"key":"e_1_3_2_29_2","volume-title":"DPP HIV-syphilis system.","author":"Chembio","year":"2018","unstructured":"Chembio. 2018. DPP HIV-syphilis system. Chembio, Medford, NY. https:\/\/www.fda.gov\/media\/142615\/download."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054358"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02959-2"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1707-8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.04.018"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2018-0182"},{"key":"e_1_3_2_35_2","volume-title":"Dear colleague letter: DSTDP lab and drug shortages.","author":"Centers for Disease Control and Prevention","year":"2020","unstructured":"Centers for Disease Control and Prevention. 2020. Dear colleague letter: DSTDP lab and drug shortages. Centers for Disease Control and Prevention, Atlanta, GA. https:\/\/www.cdc.gov\/std\/general\/DCL-Diagnostic-Test-Shortage.pdf."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/2325957416668579"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02646-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02646-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:00:45Z","timestamp":1646485245000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.02646-20"}},"subtitle":[],"editor":[{"given":"Romney M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,10,19]]}},"alternative-id":["10.1128\/JCM.02646-20"],"URL":"https:\/\/doi.org\/10.1128\/jcm.02646-20","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"2021-10-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02646-20"}}